Literature DB >> 12110306

(Z)-1,4-diamino-2-butene as a vector of boron, fluorine, or iodine for cancer therapy and imaging: synthesis and biological evaluation.

Bénédicte Martin1, Françoise Possémé, Caroline Le Barbier, François Carreaux, Bertrand Carboni, Nikolaus Seiler, Jacques-Philippe Moulinoux, Jean-Guy Delcros.   

Abstract

Polyamine vectors are attractive for tumor targeting. We envisaged (Z)-1,4-diamino-2-butene (Z-DAB), an unsaturated analogue of putrescine as vector of (10)B, (18)F and (131)I for boron neutron capture therapy (BNCT), and tumor imaging by positron emission tomography or scintigraphy respectively. In the present work, the synthesis and characterization of new derivatives of Z-DAB were reported. Z-DAB was actively transported in cells via the polyamine transport system and converted into the spermidine analogue.(E)-2-iodo-1,4-diamino-2-butene (E-I-DAB) was not taken up by the polyamine transport system and may not be suitable for tumor imaging. In contrast, (Z)-2-[4-(5,5-dimethyl-dioxaborinan-2-yl)phenyl]methyl-1,4-diamino-2-butene (Z-4-Bbz-DAB) was a substrate of the transport system and allowed significant boron accumulation in 3LL cells. Its potential in BNCT will be evaluated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110306     DOI: 10.1016/s0968-0896(02)00147-5

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Antizyme induction mediates feedback limitation of the incorporation of specific polyamine analogues in tissue culture.

Authors:  John L A Mitchell; Carrie L Simkus; Thynn K Thane; Phil Tokarz; Michelle M Bonar; Benjamin Frydman; Aldonia L Valasinas; Venodhar K Reddy; Laurence J Marton
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

2.  Comparison of interactions of diamine and Mg²⁺ with RNA tertiary structures: similar versus differential effects on the stabilities of diverse RNA folds.

Authors:  Robert J Trachman; David E Draper
Journal:  Biochemistry       Date:  2013-08-19       Impact factor: 3.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.